
CLOV Stock Forecast & Price Target
CLOV Analyst Ratings
Bulls say
Clover Health Investments is a healthcare technology company with a unique software platform, Clover Assistant, that empowers physicians to proactively manage chronic diseases and improve health outcomes while lowering medical costs. The company boasts strong retention rates in geographies where its software is adopted, indicating future financial performance. With a growing membership base and a strong focus on markets with solid density and high adoption of its technology, Clover is well-positioned for continued profitability. However, there are potential headwinds in 2027, such as a potential downgrade from a 4-star to a 3.5-star plan and flat rates from CMS, which could impact the company's profitability. Analysts believe that Clover's unique care model and strong use of technology will help manage medical cost trends and drive unit economics for the company in the future.
Bears say
Clover Health Investments is a healthcare technology company that operates in the insurance segment, providing PPO and HMO plans to Medicare Advantage members. However, several potential headwinds, including a shift from being paid as a 3.5 to a 4-star plan and a flat advance rate for 2027, could impact the company's profitability and growth. Furthermore, there are questions surrounding the company's ability to absorb a large new member cohort and retain current members. Overall, the outlook for Clover Health Investments is negative due to these concerns and potential risks to profitability and growth.
This aggregate rating is based on analysts' research of Clover Health Investments and is not a guaranteed prediction by Public.com or investment advice.
CLOV Analyst Forecast & Price Prediction
Start investing in CLOV
Order type
Buy in
Order amount
Est. shares
0 shares